1. Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms
   Kouichi Sakamoto et al, 2016 CrossRef
2. Egg Protein Transferrin-Derived Peptides IRW and IQW Regulate Citrobacter rodentium-Induced, Inflammation-Related Microbial and Metabolomic Profiles
   Yong Ma et al, 2019, Front. Microbiol. CrossRef
3. Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis
   Anna Deminger et al, 2020 CrossRef
4. Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte growth factor gene therapy for type 1 diabetes in mice
   Eriko Matsuda et al, 2021, Life Sciences CrossRef
5. Dental pulp stem cells overexpressing hepatocyte growth factor facilitate the repair of DSS-induced ulcerative colitis
   Ning Li et al, 2021, Stem Cell Res Ther CrossRef
6. Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD
   Hartwig Olga et al, 2021, Advanced Drug Delivery Reviews CrossRef
7. Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
   Maki Watanabe et al, 2021, Viruses CrossRef
8. Hepatocyte growth factor ameliorates dextran sodium sulfate‑induced colitis in a mouse model by altering the phenotype of intestinal macrophages
   Yusuke Fujino et al, 2023, Mol Med Rep CrossRef
9. Inflammatory proteins may mediate the causal relationship between gut microbiota and inflammatory bowel disease: A mediation and multivariable Mendelian randomization study
   Yu-Liang Huang et al, 2024 CrossRef
10. An optimal promoter regulating cytokine transgene expression is crucial for safe and effective oncolytic virus immunotherapy
    Hirotaka Kawakami et al, 2024, Translational Research CrossRef